RICT 2012 - Interfacing Chemical Biology and Drug Discovery
Confirmed Plenary Speakers (to Date)
Confirmed speakers
04/07/2012
08:00Registration
09:00Welcome session
Session 1: Case Studies (Kinase)
Session Chairman
Dr Pascal GEORGE
(SCT & INDEPENDENT SCIENTIFIC EXPERT & ADVISER, Longvilliers, France)
09:15Translating Structural-biology & Preclinical Activity of Nilotinib into Efficacy in Leukemia Patients
Dr Paul W. MANLEY
(NOVARTIS PHARMA, Basel, Switzerland)
10:00Matched Triplicate Design Sets in the Optimisation of a New Series of Glucokinase Activators
Prof. Mike WARING
(ASTRAZENECA, Newcastle upon Tyne, United Kingdom)
10:45Coffee Break
Session 2: Non Classical Drugs
Session Chairman
Dr Samir JEGHAM
(SANOFI R&D, MONTPELLIER, France)
11:15Synthetic Carbohydrates in the Search for Tailor-made Antibacterial Vaccines: Shigellosis as a Challenge
Dr Laurence MULARD
(INSTITUT PASTEUR, Paris, France)
12:00Bicyclic Peptide Antagonists Isolated From Phage Display Libraries
Prof. Christian HEINIS
(ECOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE (EPFL), Lausanne, Switzerland)
12:45Lunch and Poster Presentation
Session Chairman
Prof. Vincent LISOWSKI
(UNIVERSITÉ DE MONTPELLIER 1, Montpellier, France)
14:15A Look at Some Innovative Chemical Aspects in Medicinal Chemistry, about Heterocycles, Microwaves, Chemical Libraries, Boronics and Garlands
Paul Ehrlich Prize Lecture
Prof. Sylvain RAULT
(UNIVERSITÉ DE CAEN, Caen Cedex, France)
Session 3: Targeted Therapies
Session Chairman
Prof. Jean-Pierre GESSON
(UNIVERSITÉ DE POITIERS, Poitiers, France)
15:00Squalenoyl Nanomedicines as Potential Therapeutics
Dr Didier DESMAËLE
(UNIVERSITÉ PARIS SUD, Châtenay-Malabry, France)
15:45Coffee Break and Poster Session
Session Chairman
Prof. Jean-Pierre GESSON
(UNIVERSITÉ DE POITIERS, Poitiers, France)
16:15Protein-binding Prodrugs and Drug Conjugates in Oncology: From Design, Applications to Combination Therapy
Prof. Felix KRATZ
(TUMOR BIOLOGY CENTER, Freiburg, Germany)
17:00Potent Antibody Drug Conjugates for Cancer Therapy: From the Lab to a Clinically Approved Drug
Dr Peter SENTER
(SEATTLE GENETICS, Bothell, United States)
17:45Final Announcements
18:00Booster Presentations Exhibitors
05/07/2012
Session 4: Case Studies (mGLU)Session 5: Targets and Pathways
Session Chairman
Dr Luc VAN HIJFTE
(JANSSEN RESEARCH & DEVELOPMENT, Illkirch, France)
09:00JNJ-42153605: A Novel Positive Allosteric Modulator of mGluR2 for the Treatment of CNS Disorders
Dr Jose CID
(JANSSEN RESEARCH AND DEVELOPMENT, Toledo, Spain)
09:45Progress on Allosteric Modulation of mGluR5 and mGluR4: towards New Treatment Paradigms in Parkinson’s Disease
Dr Jean-Philippe ROCHER
(ADDEX THERAPEUTICS, Plan-les-Ouates, Switzerland)
Session Chairman
Prof. Dario NERI
(ETH ZÜRICH, Zürich, Switzerland)
09:00A Yeast-based Model for Prion Disease Allowed Isolation of Specific and Competitive Inhibitors of a New Protein Chaperone Activity Borne by the Ribosome that are Active Against Other Amyloid-based Diseases
Prof. Marc BLONDEL
(INSERM, Brest, France)
09:45Structure and Function of Acid-Sensing Ion Channels
Dr Stephan KELLENBERGER
(UNIVERSITÉ DE LAUSANNE, Lausanne, Switzerland)
10:30Coffee Break and Poster Session
Session 6: EpigeneticsSession 7: New Tools / Platforms
Session Chairman
Prof. Yves CENATIEMPO
(UNIVERSITÉ DE POITIERS, Poitiers Cedex, France)
11:00DNA Methylation Inhibitors In Cancer: Recent and Future Approaches
Dr Paola ARIMONDO
(CNRS - PIERRE FABRE, Toulouse, France)
11:45From ApoA1 Upregulation to BET Family Bromodomain Inhibition: Unlocking the Potential of an Epigenetic Target Class
Dr Olivier MIRGUET
(GLAXOSMITHKLINE, Les Ulis, France)
Session Chairman
Dr Olivier LAVERGNE
(., Les Ulis, France)
11:00Accelerating Drug Discovery through High Throughput Medicinal Chemistry - Alternative Lead Finding & Optimisation Approaches Including Representative Project Examples
Dr Werngard CZECHTIZKY
(SANOFI, Frankfurt am Main, Germany)
11:45Combined Use of Noncovalent Mass Spectrometry and Other Biophysical Techniques in Early-stage Drug Discovery
Dr Jean-Paul RENAUD
(NOVALIX, Ostwald, France)
12:30Lunch and Poster Session
Session 8: Exploring Chemical Space-FragmentsSession 9: Case Studies (CNS)
Session Chairman
Prof. Janos SAPI
(SCT & UNIVERSITY OF REIMS-CHAMPAGNE-ARDENNE, Reims, France)
14:00Pharmacophore-based Parallel in Silico Screening: An Interesting Concept for Efficient Activity Profiling in Drug Discovery
Prof. Dr Thierry LANGER
(PRESTWICK CHEMICAL, Vienna, Austria)
14:45Reduce to the Max – Probing Biology with Natural Product Fragments
Prof. Karl GADEMANN
(UNIVERSITY OF ZURICH, Zurich, Switzerland)
15:30Chemical space exploration via Natural Product-like compounds
Dr Jean-Yves ORTHOLAND
(EDELRIS, Lyon, France)
Session Chairman
Dr Edmond DIFFERDING
(DIFFERDING CONSULTING, Louvain-la-Neuve, Belgium)
14:00Sometimes You Just Have to Break the Rules ..
Dr Yves P. AUBERSON
(NOVARTIS INSTITUTE FOR BIOMEDICAL RESEARCH, Basel, Switzerland)
14:45Discovery of RG1678, a First in Class Glycine Reuptake Inhibitor for the Treatment of Schizophrenia
Dr Emmanuel PINARD
(F. HOFFMANN-LA ROCHE, Basel, Switzerland)
15:30SV2 Proteins Beyond Levetiracetam: The Discovery of the First SV2C Selective Ligands
Dr Anne VALADE
(UCB, Braine-l'Alleud, Belgium)
16:15Coffee Break and Poster Session
Session Chairman
Dr Pascal GEORGE
(SCT & INDEPENDENT SCIENTIFIC EXPERT & ADVISER, Longvilliers, France)
17:00Two Chemical/Biological Approaches to Alzheimer's Disease: Prevention and Therapy
Charles Mentzer Prize Lecture
Dr Laurent MEIJER
(MANROS THERAPEUTICS, Roscoff, France)
17:45Final Announcements
18:00Booster Presentations
06/07/2012
Session 10: Case Studies (Kinase)
Session Chairman
Dr Bernat VIDAL
(ALMIRALL, Barcelona, Spain)
08:45Antagonists of the p53/hdm2 Protein-Protein Interaction - Path to the Clinic
Dr Carlos GARCIA-ECHEVERRIA
(SANOFI, Vitry sur Seine, France)
09:30Sorafenib – A Signal Transduction Inhibitor for the Treatment of Liver Cancer
Dr Bernd RIEDL
(BAYER PHARMA, Wuppertal, Germany)
10:15Coffee Break and Poster Session
Session Chairman
Dr. Vincent DIVE
(CEA, Gif-sur-Yvette, France)
10:45Poster Awards and Labex Presentations
11:30Session 11: Future trends in MedChemBio
Session Chairman
Prof. Joachim MITTENDORF
(BAYER SCHERING PHARMA, Wuppertal, Germany)
11:30Perspectives in Structure and Fragment Based Drug Discovery
Prof. Rod HUBBARD
(UNIVERSITY OF YORK / VERNALIS, York, United Kingdom)
12:15Targeting Protein Interactions Mediated by Epigenetic Acetyl-lysine Reader Domains of the Bromodomain Family
Prof. Stefan KNAPP
(OXFORD UNIVERSITY, Oxford, United Kingdom)
13:00Final Conclusions
13:15Lunch
14:00End of Symposium
<Previous page


Organised by

Major Sponsors

Media Partners